Amphastar Fair Value
29
The fair market value of 29A.F stock is 66.57 EUR. Relative to the market price of 42.59 EUR Amphastar is undervalued by 56.4%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Amphastar Valuation
Current 29A.F share ticker price is 42.59 EUR.
The fair value level of 66.57 EUR can be considered as an effective entry point for long-term investors to start investing in 29A.F stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 56% lower its fair value
Current price is 9% lower its minimum value
Current price is 1405% lower its maximum value
Market price:
29A.F stock is greatly undervalued
It means the current price may concern as a Low Risk Entry Point
Amphastar Pharmaceuticals Inc Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
197.22
2
Median P/E over 5 years
20.48
3
Minimum P/E over 5 years
14.24
4
Earning per share (last 12 months)
3.44 USD
Maximum value
1
x
4
=
641.01 EUR
Fair value
2
x
4
=
66.57 EUR
Minimum value
3
x
4
=
46.27 EUR
Amphastar Pharmaceuticals Inc price metrics
22.77
Annual return (geometric mean)
42.12
Risk (standard deviation) of returns
β
0.45
Beta (volatility compared to market)